InJoong Yoon - Choong Ang Chief Officer

072020 Stock  KRW 9,690  200.00  2.11%   

Insider

InJoong Yoon is Chief Officer of Choong Ang Vaccine
Age 61
Phone(82) 42 863 8454
Webwww.cavac.co.kr

Choong Ang Management Efficiency

The company has return on total asset (ROA) of 0.056 % which means that it generated a profit of $0.056 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 8.5075 %, meaning that it generated $8.5075 on every $100 dollars invested by stockholders. Choong Ang's management efficiency ratios could be used to measure how well Choong Ang manages its routine affairs as well as how well it operates its assets and liabilities.
Choong Ang Vaccine has accumulated 5.34 B in total debt with debt to equity ratio (D/E) of 6.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Choong Ang Vaccine has a current ratio of 5.15, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Choong Ang until it has trouble settling it off, either with new capital or with free cash flow. So, Choong Ang's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Choong Ang Vaccine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Choong to invest in growth at high rates of return. When we think about Choong Ang's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Dong LeeHLB Pharmaceutical Co
51
Yeong JeonHLB Pharmaceutical Co
45
KyungII KimAminologics CoLtd
65
Jeong YoonHLB Pharmaceutical Co
49
Yong ChoHLB Pharmaceutical Co
53
YoonWoo LeeDaihan Pharmaceutical CoLtd
79
DongYeop LeeHLB Pharmaceutical Co
60
SangWoo LeeKolon Life Science
59
KukHwan ChoiSam A Pharm Co
59
MyungKwan SuhKolon Life Science
61
JaeGwan LeeAminologics CoLtd
64
SangJun LeeKolon Life Science
62
TaeHwan KimKolon Life Science
73
HyeonWu LeeSam A Pharm Co
63
JongBin KimHLB Pharmaceutical Co
67
ShinJun KangSam A Pharm Co
58
Jae NohHLB Pharmaceutical Co
43
Dae SonHLB Pharmaceutical Co
46
Jong KimHLB Pharmaceutical Co
58
WonSup KimAminologics CoLtd
64
WanJoo KimHLB Pharmaceutical Co
N/A
Choong Ang Vaccine Laboratory Co., Ltd. engages in the production and sale of animal biological products primarily in Korea. The company, formerly known as ChoongAng Veterinary Infectious Diseases Research Institute, was founded in 1968 and is based in Daejeon, South Korea. CAVAC is traded on Korean Securities Dealers Automated Quotations in South Korea. Choong Ang Vaccine (072020) is traded on KOSDAQ in Korea and employs 162 people.

Management Performance

Choong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Choong Ang a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Choong Ang

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Choong Ang position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Choong Ang will appreciate offsetting losses from the drop in the long position's value.

Moving together with Choong Stock

  0.92074430 Aminologics CoLtdPairCorr

Moving against Choong Stock

  0.36030200 KT CorporationPairCorr
  0.33011200 HMM CoPairCorr
The ability to find closely correlated positions to Choong Ang could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Choong Ang when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Choong Ang - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Choong Ang Vaccine to buy it.
The correlation of Choong Ang is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Choong Ang moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Choong Ang Vaccine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Choong Ang can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Choong Stock

Choong Ang financial ratios help investors to determine whether Choong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Choong with respect to the benefits of owning Choong Ang security.